1-12 of 12
Douglas S. Micalizzi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 257: The E3 ligase HECTD4 regulates COX-2 dependent tumor progression and metastasis

Free
Joanna Vuille, Cem Tanriover, Douglas S. Micalizzi, Richard Y. Ebright, Sambhavi Animesh, Robert Morris, Soroush Hajizadeh, Zachary J. Nicholson, Hunter C. Russell, Eric F. Zaniewski, Ben S. Wittner, Ben K. Wesley, Julian Grünewald, Regan N. Szalay, Ezgi Antmen, Douglas B. Fox, Min Yang, Jae Keith Joung, Doga C. Gulhan, Andrew E. Elia, Wilhelm Haas, Eugene Oh, Shyamala Maheswaran, Daniel A. Haber
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 257.
https://doi.org/10.1158/1538-7445.AM2025-257
Published: 21 April 2025
View articletitled, Abstract 257: The E3 ligase HECTD4 regulates COX-2 dependent tumor progression and metastasis
Journal Articles

Abstract PD13-07: PD13-07 Combination therapy with the AKT inhibitor, ipatasertib, endocrine therapy, and a CDK4/6 inhibitor for hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC): results from the phase I TAKTIC trial

Free
Seth A. Wander, Jennifer C. Keenan, Andrzej Niemierko, Dejan Juric, Laura M. Spring, Jeffrey Supko, Neelima Vidula, Steven J. Isakoff, Lianne Ryan, Sarah Padden, Elizabeth Fisher, Amber Newton, Beverly Moy, Leif Ellisen, Douglas S. Micalizzi, Aditya Bardia
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD13-07.
https://doi.org/10.1158/1538-7445.SABCS22-PD13-07
Published: 01 March 2023
View articletitled, Abstract PD13-07: PD13-07 Combination therapy with the AKT inhibitor, ipatasertib, endocrine therapy, and a CDK4/6 inhibitor for hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC): results from the phase I TAKTIC trial
Journal Articles

Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition

Available to Purchase
Nezihi Murat Karabacak, Yu Zheng, Taronish D. Dubash, Risa Burr, Douglas S. Micalizzi, Ben S. Wittner, Maoxuan Lin, Devon F. Wiley, Valentine Comaills, Erin Emmons, Kira L. Niederhoffer, Uyen Ho, Jacob Ukleja, Dante Che, Hannah Stowe, Linda T. Nieman, Wilhelm Haas, Shannon L. Stott, Michael S. Lawrence, David T. Ting, David T. Miyamoto, Daniel A. Haber, Mehmet Toner, Shyamala Maheswaran
Journal: Cancer Research
Cancer Res (2022) 82 (6): 1084–1097.
https://doi.org/10.1158/0008-5472.CAN-21-2609
Published: 15 March 2022
View articletitled, Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition
Open the PDF for Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition in another window
Includes: Supplementary data
Journal Articles

Abstract P1-18-22: AKT inhibition in combination with endocrine therapy and a CDK4/6 inhibitor (CDK4/6i) in patients with hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC) and prior CDK4/6i exposure: A translational investigation

Free
Seth A. Wander, Douglas S. Micalizzi, Taronish Dubash, Dejan Juric, Laura M. Spring, Neelima Vidula, Jennifer Keenan, Maureen Beeler, Elene Viscosi, Dante Che, Elizabeth L. Fisher, Rachel A. Hepp, Beverly Moy, Steven J. Isakoff, Leif W. Ellisen, Jeffrey G. Supko, Shyamala Maheswaran, Daniel A. Haber, Aditya Bardia
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-18-22.
https://doi.org/10.1158/1538-7445.SABCS21-P1-18-22
Published: 15 February 2022
View articletitled, Abstract P1-18-22: AKT inhibition in combination with endocrine therapy and a CDK4/6 inhibitor (CDK4/6i) in patients with hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC) and prior CDK4/6i exposure: A translational investigation
Journal Articles

Translational Regulation of Cancer Metastasis

Available to Purchase
Douglas S. Micalizzi, Richard Y. Ebright, Daniel A. Haber, Shyamala Maheswaran
Journal: Cancer Research
Cancer Res (2021) 81 (3): 517–524.
https://doi.org/10.1158/0008-5472.CAN-20-2720
Published: 01 February 2021
View articletitled, Translational Regulation of Cancer Metastasis
Open the PDF for Translational Regulation of Cancer Metastasis in another window
Journal Articles

Abstract P1-13-03: Association of PIK3CA mutation with clinical response to specific endocrine therapies in metastatic hormone receptor positive (HR+) breast cancer

Free
Douglas S Micalizzi, Dejan Juric, Andrzej Niemierko, Kerry L Reynolds, Darrell Borger, Sadhna R Vora, Steven J Isakoff, Beverly Moy, Leif W Ellisen, Aditya Bardia
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P1-13-03.
https://doi.org/10.1158/1538-7445.SABCS14-P1-13-03
Published: 01 May 2015
View articletitled, Abstract P1-13-03: Association of PIK3CA mutation with clinical response to specific endocrine therapies in metastatic hormone receptor positive (HR+) breast cancer
Journal Articles

Abstract 782: The Six1 homeoprotein downregulates p53, via a novel, MDM2 independent mechanism.

Free
Christina N. Garlington, Douglas S. Micalizzi, Heide L. Ford
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 782.
https://doi.org/10.1158/1538-7445.AM2013-782
Published: 15 April 2013
View articletitled, Abstract 782: The Six1 homeoprotein downregulates p53, via a novel, MDM2 independent mechanism.
Journal Articles

Abstract A20: The Six1-regulated miR-106b-25 cluster is a mediator of the tumor promotional effects of TGF-β signaling in human breast cancer

Free
Anna L. Smith, Ritsuko Iwanaga, David J. Drasin, Douglas S. Micalizzi, Rebecca L. Vartuli, Heide L. Ford
Journal: Cancer Research
Cancer Res (2012) 72 (2_Supplement): A20.
https://doi.org/10.1158/1538-7445.NONRNA12-A20
Published: 03 April 2013
View articletitled, Abstract A20: The Six1-regulated miR-106b-25 cluster is a mediator of the tumor promotional effects of TGF-β signaling in human breast cancer
Journal Articles

Abstract 1463: SIX1 induces lymphatic and distant metastasis by upregulating VEGF-C and stimulating lymphangiogenesis in breast cancer

Free
Chu-An Wang, Paul Jedlicka, Kimberly L. Christensen, Douglas S. Micalizzi, J. Chuck Harrell, Heide L. Ford
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1463.
https://doi.org/10.1158/1538-7445.AM2011-1463
Published: 15 April 2011
View articletitled, Abstract 1463: SIX1 induces lymphatic and distant metastasis by upregulating VEGF-C and stimulating lymphangiogenesis in breast cancer
Journal Articles

Homeoprotein Six1 Increases TGF-β Type I Receptor and Converts TGF-β Signaling from Suppressive to Supportive for Tumor Growth

Free
Douglas S. Micalizzi, Chu-An Wang, Susan M. Farabaugh, William P. Schiemann, Heide L. Ford
Journal: Cancer Research
Cancer Res (2010) 70 (24): 10371–10380.
https://doi.org/10.1158/0008-5472.CAN-10-1354
Published: 14 December 2010
View articletitled, Homeoprotein Six1 Increases TGF-β Type I Receptor and Converts TGF-β Signaling from Suppressive to Supportive for Tumor Growth
Open the PDF for Homeoprotein Six1 Increases TGF-β Type I Receptor and Converts TGF-β Signaling from Suppressive to Supportive for Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Abstract #1045: Six1 induces VEGF-C, lymphangiogenesis and metastasis of breast cancer cells

Free
Chu-an Wang, Kimberly L. Christensen, Douglas S. Micalizzi, Paul Jedlicka, J. Chuck Harrell, Kathryn B. Horwitz, Heide L. Ford
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1045.
Published: 01 May 2009
View articletitled, Abstract #1045: Six1 induces VEGF-C, lymphangiogenesis and metastasis of breast cancer cells
Journal Articles

Six1 Overexpression in Mammary Cells Induces Genomic Instability and Is Sufficient for Malignant Transformation

Free
Ricardo D. Coletta, Kimberly L. Christensen, Douglas S. Micalizzi, Paul Jedlicka, Marileila Varella-Garcia, Heide L. Ford
Journal: Cancer Research
Cancer Res (2008) 68 (7): 2204–2213.
https://doi.org/10.1158/0008-5472.CAN-07-3141
Published: 01 April 2008
View articletitled, Six1 Overexpression in Mammary Cells Induces Genomic Instability and Is Sufficient for Malignant Transformation
Open the PDF for Six1 Overexpression in Mammary Cells Induces Genomic Instability and Is Sufficient for Malignant Transformation in another window
Includes: Supplementary data